Regenique Group Limited (RGGG)
Regenique Group will go public soon, but the exact IPO date is still unknown.
IPO Price Range
$4.00 - $5.00
Shares Offered
2,000,000
Deal Size
$9.00M
Company Description
Regenique Group is a customer-centric, science-backed aesthetics services provider.
We prioritize delivering an unparalleled, premium experience for our customers by emphasizing safety, privacy and patient comfort.
In addition to the market’s prevailing medi-aesthetics treatments, our suite of science-backed aesthetics services also includes bio-regenerative treatments and other advanced therapies.
Our services are rendered through five strategically located clinics staffed by experienced doctors and equipped with advanced medical devices.
Our mission is to elevate the overall well-being of our customers by offering personalized anti-aging and longevity healthcare and aesthetics solutions.
Regenique Group Limited
| Country | Singapore |
| Founded | 2009 |
| Industry | Medical Care Facilities |
| Sector | Healthcare |
| Employees | 58 |
| CEO | Mr. Wong Ming Kwong |
Contact Details
Address: 10 Sinara Drive #10-25 Square 2, 307506 Singapore | |
| Phone | +65 8383 0544 |
| Website | regeniquegroup.com |
Stock Details
| Ticker Symbol | RGGG |
| Exchange | NASDAQ |
| Fiscal Year | October - September |
| Reporting Currency | SGD |
| CIK Code | 0002063022 |
| SIC Code | 8011 |
Key Executives
| Name | Position |
|---|---|
| Mr. Wong Ming Kwong | Executive Chairman and Chief Executive Officer |
| Mr. Then Chee Tat | Executive Director, Chief Financial Officer and Deputy Chief Executive Officer |
| Dr. Shiau Ee Leng | Chief Medical Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Oct 31, 2025 | F-1 | Registration statement for certain foreign private issuers |
| Sep 2, 2025 | DRS/A | [Amend] [Cover] Draft Registration Statement |
| Aug 8, 2025 | DRS/A | [Amend] [Cover] Draft Registration Statement |
| Jul 18, 2025 | DRS/A | [Amend] [Cover] Draft Registration Statement |
| May 23, 2025 | DRS | [Cover] Draft Registration Statement |